Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$4.96B |
| 2 |
SUNB
Sunbelt Rentals Holdings
SUNB
|
+$201M |
| 3 |
Palo Alto Networks
PANW
|
+$141M |
| 4 |
Johnson & Johnson
JNJ
|
+$141M |
| 5 |
Rayonier
RYN
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$605M |
| 2 |
Broadcom
AVGO
|
+$425M |
| 3 |
NVIDIA
NVDA
|
+$412M |
| 4 |
Microsoft
MSFT
|
+$347M |
| 5 |
CYBR
CyberArk
CYBR
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.6% |
| 2 | Financials | 12.66% |
| 3 | Healthcare | 10.78% |
| 4 | Communication Services | 9.19% |
| 5 | Consumer Discretionary | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKTS
2801
Aktis Oncology
AKTS
$1.32B
| $32.7K | ﹤0.01% |
+1,826
| New | +$35.5K |
|
2802
Climb Global Solutions
CLMB
$473M
| $32.7K | ﹤0.01% |
1,648
-36
| -2% | -$933 |
|
2803
Marcus Corp
MCS
$732M
| $32.6K | ﹤0.01% |
1,900
| – | – |
|
2804
Vanda Pharmaceuticals
VNDA
$312M
| $32.6K | ﹤0.01% |
4,716
| – | – |
|
|
LAND
2805
Gladstone Land Corp
LAND
$368M
| $32.4K | ﹤0.01% |
3,175
| – | – |
|
2806
West Bancorporation
WTBA
$464M
| $32.4K | ﹤0.01% |
1,361
-52
| -4% | -$1.24K |
|
2807
Lexeo Therapeutics
LXEO
$366M
| $32.3K | ﹤0.01% |
5,631
| – | – |
|
2808
Pacific Biosciences
PACB
$422M
| $32.3K | ﹤0.01% |
24,447
| – | – |
|
2809
Entrada Therapeutics
TRDA
$227M
| $32.3K | ﹤0.01% |
2,557
| – | – |
|
2810
Movado Group
MOV
$812M
| $32.3K | ﹤0.01% |
1,321
| – | – |
|
2811
Caleres
CAL
$396M
| $32K | ﹤0.01% |
3,036
| – | – |
|
|
SFIX
2812
Stitch Fix
SFIX
$478M
| $32K | ﹤0.01% |
9,657
-92
| -0.9% | -$375 |
|
2813
Atea Pharmaceuticals
AVIR
$379M
| $31.9K | ﹤0.01% |
5,933
| – | – |
|
2814
Ranger Energy Services
RNGR
$373M
| $31.9K | ﹤0.01% |
1,860
| – | – |
|
2815
Titan Machinery
TITN
$466M
| $31.8K | ﹤0.01% |
1,904
| – | – |
|
2816
iHeartMedia
IHRT
$535M
| $31.7K | ﹤0.01% |
10,846
| – | – |
|
|
NPB
2817
Northpointe Bancshares
NPB
$594M
| $31.6K | ﹤0.01% |
1,831
| – | – |
|
2818
RBB Bancorp
RBB
$446M
| $31.6K | ﹤0.01% |
1,477
| – | – |
|
2819
Capital Bancorp
CBNK
$588M
| $31.5K | ﹤0.01% |
1,060
-54
| -5% | -$1.62K |
|
2820
Spire Global
SPIR
$425M
| $31.4K | ﹤0.01% |
2,499
-431
| -15% | -$4.61K |
|
2821
Dine Brands
DIN
$432M
| $31.4K | ﹤0.01% |
1,195
-200
| -14% | -$6.49K |
|
2822
Cerus
CERS
$587M
| $31.3K | ﹤0.01% |
17,205
-2,738
| -14% | -$5.97K |
|
2823
Verastem
VSTM
$532M
| $31.2K | ﹤0.01% |
5,887
+600
| +11% | +$3.7K |
|
2824
First Bank
FRBA
$451M
| $31.2K | ﹤0.01% |
1,949
| – | – |
|
|
TECX
2825
Tectonic Therapeutic
TECX
$573M
| $30.9K | ﹤0.01% |
1,000
-50
| -5% | -$1.23K |
|
Similar funds
Legal & General Group's Q1 2026 Portfolio in Review
As of Q1 2026, Legal & General Group held 3,422 positions worth $432B, down 4.1% from $451B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 2.7%. Legal & General Group opened 34 new positions and exited 60, leaving the 3,422-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,857,761 shares worth $179M.
- Legal & General Group added most to AstraZeneca in Q1 2026, an estimated $4.96B increase.
- Legal & General Group's biggest Q1 2026 reduction was Apple, cutting an estimated $605M.
- Legal & General Group fully exited CyberArk in Q1 2026, selling an estimated $238M.
- Legal & General Group's ten largest holdings make up 32% of its $432B portfolio in Q1 2026.
- Legal & General Group opened 34 new positions and closed 60 in Q1 2026.
- Legal & General Group's portfolio value fell 4.1% quarter-over-quarter to $432B.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.